Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica.

Birra D, Bosello SL, Peluso G, Zoli A.

Clin Exp Rheumatol. 2019 Dec 11. [Epub ahead of print]

PMID:
31858957
2.

Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study.

Negrini S, Magnani O, Matucci-Cerinic M, Carignola R, Data V, Montabone E, Santaniello A, Adorni G, Murdaca G, Puppo F, Indiveri F, Della Rossa A, D'Ascanio A, Barsotti S, Giuggioli D, Ferri C, Lumetti F, Bosello SL, Canestrari G, Bellando Randone S, Bruni C, Guiducci S, Battaglia E, De Andres MI, Russo AA, Beretta L.

Clin Exp Med. 2019 Aug;19(3):357-366. doi: 10.1007/s10238-019-00553-y. Epub 2019 Apr 15.

PMID:
30989453
3.

Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy.

Fedele AL, Petricca L, Tolusso B, Alivernini S, Canestri S, Di Mario C, Bosello SL, Ferraccioli G, Gremese E.

Scand J Rheumatol. 2018 Sep;47(5):351-359. doi: 10.1080/03009742.2017.1416668. Epub 2018 Mar 15.

PMID:
29542372
4.

QTc interval prolongation in Systemic Sclerosis: Correlations with clinical variables and arrhythmic risk.

De Luca G, Bosello SL, Canestrari G, Cavalli G, Dagna L, Ferraccioli G.

Int J Cardiol. 2017 Jul 15;239:33. doi: 10.1016/j.ijcard.2017.03.088. No abstract available.

PMID:
28560978
5.

The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU).

Biscetti F, Carbonella A, Parisi F, Bosello SL, Schiavon F, Padoan R, Gremese E, Ferraccioli G.

Medicine (Baltimore). 2016 Nov;95(48):e5506.

6.

Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome.

De Luca G, Bosello SL, Gabrielli FA, Berardi G, Parisi F, Rucco M, Canestrari G, Loperfido F, Galiuto L, Crea F, Ferraccioli G.

PLoS One. 2016 Apr 21;11(4):e0153012. doi: 10.1371/journal.pone.0153012. eCollection 2016.

7.

Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone.

Carbonella A, Berardi G, Petricca L, Biscetti F, Alivernini S, Bosello SL, Fedele AL, Ferraccioli G, Gremese E.

J Am Geriatr Soc. 2016 Mar;64(3):672-374. doi: 10.1111/jgs.14004. No abstract available.

PMID:
27000356
8.

Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk.

De Luca G, Bosello SL, Berardi G, Rucco M, Canestrari G, Correra M, Mirone L, Forni F, Di Mario C, Danza FM, Pirronti T, Ferraccioli G.

Rheumatology (Oxford). 2015 Nov;54(11):1991-9. doi: 10.1093/rheumatology/kev204. Epub 2015 Jun 22.

PMID:
26106211
9.

Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography.

Peluso G, Bosello SL, Gremese E, Mirone L, Di Gregorio F, Di Molfetta V, Pirronti T, Ferraccioli G.

Clin Rheumatol. 2015 Jul;34(7):1181-6. doi: 10.1007/s10067-015-2938-6. Epub 2015 Apr 23.

PMID:
26091903
10.

Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.

Bosello SL, De Luca G, Rucco M, Berardi G, Falcione M, Danza FM, Pirronti T, Ferraccioli G.

Semin Arthritis Rheum. 2015 Feb;44(4):428-36. doi: 10.1016/j.semarthrit.2014.09.002. Epub 2014 Sep 8.

PMID:
25300701
11.

Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis.

Fedele AL, Tolusso B, Gremese E, Bosello SL, Carbonella A, Canestri S, Ferraccioli G.

BMC Immunol. 2014 Sep 4;15:28. doi: 10.1186/s12865-014-0028-1.

12.

Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study.

Gremese E, Salaffi F, Bosello SL, Ciapetti A, Bobbio-Pallavicini F, Caporali R, Ferraccioli G.

Ann Rheum Dis. 2013 Jun;72(6):858-62. doi: 10.1136/annrheumdis-2012-201456. Epub 2012 Jul 13.

13.

A vascular endothelial growth factor deficiency characterises scleroderma lung disease.

De Santis M, Bosello SL, Capoluongo E, Inzitari R, Peluso G, Lulli P, Zizzo G, Bocci M, Tolusso B, Zuppi C, Castagnola M, Ferraccioli G.

Ann Rheum Dis. 2012 Sep;71(9):1461-5. doi: 10.1136/annrheumdis-2011-200657. Epub 2012 Mar 8.

PMID:
22402140
14.

The human salivary proteome: a critical overview of the results obtained by different proteomic platforms.

Castagnola M, Cabras T, Iavarone F, Fanali C, Nemolato S, Peluso G, Bosello SL, Faa G, Ferraccioli G, Messana I.

Expert Rev Proteomics. 2012;9(1):33-46. doi: 10.1586/epr.11.77. Review.

PMID:
22292822
15.

PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis.

Totaro MC, Tolusso B, Napolioni V, Faustini F, Canestri S, Mannocci A, Gremese E, Bosello SL, Alivernini S, Ferraccioli G.

PLoS One. 2011;6(9):e24292. doi: 10.1371/journal.pone.0024292. Epub 2011 Sep 16.

16.

Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease.

De Santis M, Bosello SL, Peluso G, Pinnelli M, Alivernini S, Zizzo G, Bocci M, Capacci A, La Torre G, Mannocci A, Pagliari G, Varone F, Pistelli R, Danza FM, Ferraccioli G.

Clin Respir J. 2012 Jan;6(1):9-17. doi: 10.1111/j.1752-699X.2010.00228.x. Epub 2010 Nov 25.

PMID:
21801327
17.

B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status.

Michelutti A, Gremese E, Morassi F, Petricca L, Arena V, Tolusso B, Alivernini S, Peluso G, Bosello SL, Ferraccioli G.

Mol Med. 2011 Sep-Oct;17(9-10):901-9. doi: 10.2119/molmed.2011.00034. Epub 2011 May 13.

18.

β-Thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up.

De Santis M, Inzitari R, Bosello SL, Peluso G, Fanali C, Iavarone F, Zizzo G, Bocci M, Cabras T, Messana I, Fuso L, Varone F, Pagliari G, Castagnola M, Ferraccioli G.

Respir Res. 2011 Feb 11;12:22. doi: 10.1186/1465-9921-12-22.

19.

Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis.

Zizzo G, De Santis M, Bosello SL, Fedele AL, Peluso G, Gremese E, Tolusso B, Ferraccioli G.

Clin Immunol. 2011 Jan;138(1):107-16. doi: 10.1016/j.clim.2010.10.002. Epub 2010 Nov 5.

PMID:
21056009
20.

Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease.

Ferraccioli G, De Santis M, Peluso G, Inzitari R, Fanali C, Bosello SL, Iavarone F, Castagnola M.

Autoimmun Rev. 2010 Jul;9(9):622-6. doi: 10.1016/j.autrev.2010.05.010. Epub 2010 May 10. Review.

PMID:
20462525
21.

Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios.

Pietrapertosa D, Tolusso B, Gremese E, Papalia MC, Bosello SL, Peluso G, Petricca L, Michelutti A, Faustini F, Fedele AL, Ferraccioli G.

Clin Chem Lab Med. 2010 Jun;48(6):829-34. doi: 10.1515/CCLM.2010.152.

PMID:
20298138
22.

Residual minimal disease activity in rheumatoid arthritis: a simple definition through an in-depth statistical analysis of the major outcome.

Pietrapertosa D, Salaffi F, Peluso G, Bosello SL, Fedele AL, Cuoghi I, Michelutti A, Gremese E, Ferraccioli GF.

Rheumatology (Oxford). 2009 Oct;48(10):1242-6. doi: 10.1093/rheumatology/kep217. Epub 2009 Jul 27.

PMID:
19635732
23.

Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing.

Alivernini S, De Santis M, Tolusso B, Mannocci A, Bosello SL, Peluso G, Pinnelli M, D'Antona G, La Torre G, Ferraccioli G.

J Am Acad Dermatol. 2009 Mar;60(3):426-35. doi: 10.1016/j.jaad.2008.11.025. Erratum in: J Am Acad Dermatol. 2015 Apr;72(4):748. LaTorre, Giuseppe [Corrected to La Torre, Giuseppe].

PMID:
19231640

Supplemental Content

Loading ...
Support Center